72 Investment Holdings, LLC
72 Investment Holdings, LLC is a subsidiary or affiliated entity managed under the Point72 Asset Management umbrella, headquartered in Stamford, CT, United States. Founded by Steven A. Cohen, the wider firm traces roots back to 2014, though 72 Investment Holdings appears to be a special purpose vehicle differentiated in SEC filings. Point72 currently manages over 2,900 employees globally and provides investment management services primarily to institutional investors and qualified clients, employing deep fundamental research and systematic strategies across asset classes.
Investment Strategy
72 Investment Holdings, LLC primarily invests in public equities, with a concentrated portfolio heavily weighted in biotechnology and healthcare innovation firms. The fund typically focuses on high-conviction positions with rigorous research, often leveraging Point72’s broader investment resources. The top holdings as of Q1 2025 are dominated by biotech companies, suggesting a specialized thematic focus. The approach appears to be opportunistic, seeking outsized returns through concentrated bets backed by fundamental analysis, often paralleling the investment philosophy of the broader Point72 organization.
Top Holdings
Equity Positions (6)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
L LENZ | LENZ THERAPEUTICS INC | 77.84% | $29.8M | 1,017,751 | $21.01 | $29.31 | +$3.7M |
K KRRO | KORRO BIO INC | 9.02% | $3.5M | 276,831 | $47.93 | $12.49 | -$1.4M |
P PRAX | PRAXIS PRECISION MEDICINES I | 7.23% | $2.8M | 65,933 | $22.28 | $42.05 | +$275.6K |
A ANRO | ALTO NEUROSCIENCE INC | 3.83% | $1.5M | 667,778 | $14.56 | $2.20 | +$26.7K |
C CRBU | CARIBOU BIOSCIENCES INC | 1.56% | $597.3K | 474,067 | $23.87 | $1.26 | +$164.5K |